| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,129 |
10,991 |
$1.87M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,347 |
6,268 |
$1.55M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,333 |
4,276 |
$1.43M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,395 |
1,372 |
$180K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,182 |
614 |
$159K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,061 |
1,016 |
$54K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
523 |
516 |
$50K |
| 87428 |
|
1,222 |
1,219 |
$41K |
| 36415 |
Collection of venous blood by venipuncture |
5,821 |
5,570 |
$40K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,452 |
5,301 |
$36K |
| 80053 |
Comprehensive metabolic panel |
3,976 |
3,870 |
$36K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,073 |
1,036 |
$29K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
145 |
143 |
$24K |
| 71045 |
Radiologic examination, chest; single view |
1,522 |
1,489 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
142 |
141 |
$10K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
219 |
217 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
193 |
192 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
159 |
156 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,243 |
1,213 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
361 |
359 |
$5K |
| 87400 |
|
200 |
197 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
68 |
66 |
$4K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
96 |
96 |
$4K |
| 81025 |
|
457 |
446 |
$4K |
| 84484 |
|
307 |
300 |
$3K |
| 83690 |
|
548 |
528 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
51 |
50 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
190 |
188 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
37 |
36 |
$2K |
| 97597 |
|
253 |
139 |
$2K |
| 81003 |
|
872 |
863 |
$2K |
| 87081 |
|
243 |
241 |
$1K |
| 87807 |
|
106 |
106 |
$1K |
| 81001 |
|
382 |
380 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
105 |
105 |
$728.95 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
157 |
111 |
$562.28 |
| 83880 |
|
14 |
12 |
$482.44 |
| 84443 |
Thyroid stimulating hormone (TSH) |
26 |
26 |
$358.56 |
| 80061 |
Lipid panel |
24 |
24 |
$303.71 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
39 |
39 |
$274.61 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
802 |
781 |
$165.28 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
26 |
24 |
$24.32 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
50 |
48 |
$2.16 |
| J7050 |
Infusion, normal saline solution, 250 cc |
338 |
331 |
$0.78 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
12 |
12 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
19 |
19 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
215 |
214 |
$0.00 |